Burosumab – March 2026

  • Brand names:
    • Crysvita ®
  • Pharmaceutical Company:
    • KYOWA KIRIN AUSTRALIA PTY LTD
  • Condition/Indication: Tumour induced osteomalacia (TIO)
  • Meeting Date: March 2026
Public Summary Documents
Last updated
13 November 2026